Page last updated: 2024-09-02

hydroxyitraconazole and fluconazole

hydroxyitraconazole has been researched along with fluconazole in 4 studies

Compound Research Comparison

Studies
(hydroxyitraconazole)
Trials
(hydroxyitraconazole)
Recent Studies (post-2010)
(hydroxyitraconazole)
Studies
(fluconazole)
Trials
(fluconazole)
Recent Studies (post-2010) (fluconazole)
8729229,3437213,664

Protein Interaction Comparison

ProteinTaxonomyhydroxyitraconazole (IC50)fluconazole (IC50)
Lanosterol 14-alpha demethylaseCandida albicans SC53140.1296
Cytochrome P450 2C9 Homo sapiens (human)9.21
Sterol 14-alpha demethylaseTrypanosoma cruzi strain CL Brener0.88

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE1
Backman, JT; Karonen, T; Laitila, J; Neuvonen, PJ; Niemi, M1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ1
Basu, SS; Jarolim, P; Mason, DS; Petrides, A1

Trials

1 trial(s) available for hydroxyitraconazole and fluconazole

ArticleYear
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
    European journal of clinical pharmacology, 2012, Volume: 68, Issue:5

    Topics: Adult; Anti-Asthmatic Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Genetic Association Studies; Half-Life; Humans; Indoles; Itraconazole; Leukotriene Antagonists; Male; Phenylcarbamates; Polymorphism, Genetic; Sulfonamides; Tosyl Compounds; Young Adult

2012

Other Studies

3 other study(ies) available for hydroxyitraconazole and fluconazole

ArticleYear
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2009
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole

2016
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
    Clinical chemistry and laboratory medicine, 2017, May-01, Volume: 55, Issue:6

    Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole

2017